| Takeda Pharma AG - Elvanse 30 mg, Hartkapseln | | 63023 | | 01 | | Elvanse 30 mg | | Hartkapseln | | N06BA12 | | Lisdexamfetamine | | 27.03.2014 | | |
| | Composition | | lisdexamfetamini dimesilas 30 mg corresp. dexamfetaminum 8.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 127, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.383612 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Active Agent | Dose |
|---|
| Lisdexamfetamini Dimesilas | 30 mg correspond Dexamfetaminum 8.9 mg |
| | BAG: Active Agent | Dose |
|---|
| Lisdexamfetamini Dimesilas | 30 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 127 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 Capsule(s) | 86.89 | 108.25 | A+ | SL | Yes |
|
|
